Moreover, the influence of Neratinib on the cell senescence in AU565 cells was rescued by overexpressing SIRT1, implying that Neratinib might induce the cell senescence in mammary cancer cells by downregulating SIRT1. This evidence concerns the gene SIRT1 and breast cancer.